Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response. - Wikidata - awgldk - TriplyDB

Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.

Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.

http://www.wikidata.org/entity/Q35314135

about

Molecular Classification of Triple-Negative Breast Cancer Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.RNA Sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women Re-expression of miR-200c suppresses proliferation, colony formation and in vivo tumor growth of murine claudin-low mammary tumor cells.Gene-expression signature functional annotation of breast cancer tumours in function of age Basal-like breast cancer: molecular profiles, clinical features and survival outcomes Survivin contributes to DNA repair by homologous recombination in breast cancer cells.Role of the androgen receptor in triple-negative breast cancer.Cancer stem cells and early stage basal-like breast cancer.AR Signaling in Breast Cancer.Development and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancer.Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer.ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor-positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines.Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.Triple Negative Breast Cancer at the University Hospital Mohammed VI – Oujda Targeting the androgen receptor in triple-negative breast cancer.A review of the importance of immune responses in luminal B breast cancer.Exploring phenotype patterns of breast cancer within somatic mutations: a modicum in the intrinsic code.Overexpression of Uridine-Cytidine Kinase 2 Correlates with Breast Cancer Progression and Poor Prognosis.Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database.PD-L1 and intratumoral immune response in breast cancer.CD74 and intratumoral immune response in breast cancer.Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance.Gene expression information improves reliability of receptor status in breast cancer patients.The Landscape of Small Non-Coding RNAs in Triple-Negative Breast Cancer.Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer.A novel patient-derived xenograft model for claudin-low triple-negative breast cancer.Pathological response in a triple negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann's refined classification.Androgen receptor-positive, triple-negative breast cancer.Expression of ROR1 has prognostic significance in triple negative breast cancer.Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features.Alterations of Signaling Pathways Related to the Immune System in Breast Cancer: New Perspectives in Patient Management The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge Triple-negative breast cancer and the potential for targeted therapy Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation Detection of PIK3/AKT pathway in Moroccan population with triple negative breast cancer Transcriptome Signatures of Canine Mammary Gland Tumors and Its Comparison to Human Breast Cancers

P2860

Q28076661-8C9F4A6C-D6CE-4DE0-B094-2329EE5AE6AB Q30245184-27EC9C5A-B024-4866-B57E-B5C2B4E86B62 Q31138624-B3F26532-C7F9-48CE-8D98-949DA2F665CC Q33618290-4607E423-D633-4920-BC55-EB3015884EC0 Q33618841-01822203-6CCF-4D05-A73E-6AFA92FC5E70 Q35849104-890F61A2-5081-4234-9956-4C87B67BD134 Q36325873-950845BB-E573-41D0-8BD9-F7BD95E83E51 Q36441625-CCA42355-BE5D-42BB-9ECF-625F4D458FC2 Q37573317-D9E7BAA7-5750-4C5B-AC3F-55611F607687 Q37660438-EA12C250-18CD-4BF8-8376-46F154EA51D5 Q37721492-9BFEF0F5-B6E2-4776-BB22-5EBFE200F250 Q38383094-511DAB2A-C876-473D-90BD-A52568345E7F Q38552128-ED27C13B-1411-4943-9002-B27F4C2AE8D5 Q38788928-F96EDBF3-0CCA-44AA-A2C7-5954674ED9F7 Q38809040-40A445E0-A75C-4F97-BEAA-ED519CC69A26 Q38853361-70F8643F-66CD-42FB-8D21-3691CFD630CF Q38940118-288AB1BA-909E-46D1-A5D3-B297169E6AFE Q38999707-F025534D-88EC-4FC8-B536-31F65075200B Q39239484-568AA3DE-D227-41AF-A5DE-F78EAF4D5254 Q39752527-660FCFC0-F0E1-4BB7-AB2C-DE6A319EBD72 Q40130042-05C7BD0B-F89F-4738-95A1-9F94EEC25853 Q40553911-44D74429-0335-4F22-A577-FD8A165497E0 Q41612935-22649811-1CB0-4886-B7DC-472A1161154E Q41808474-47EEDF45-19E4-47E5-8394-8609438BBB48 Q42378844-3CB250D6-FBA5-4319-8BDA-FC0C3D90489C Q42517334-C124828A-C9EC-4787-A7DF-FDADDF0823D4 Q43654815-75FBB975-E3E6-44A9-98DC-F83449FAB3F5 Q47213893-7F0CC424-146E-4A2C-8861-EEB6E574955B Q47638243-2E837A19-D037-4AE3-8177-590265C8FFCC Q48118338-6929390A-FDFF-43DC-89BC-EDC8715F6ACB Q48148198-9324130F-E99B-44D3-9DC0-3FBBB74C18B9 Q48280041-285B0835-D9BD-4778-9DF3-59402AC47F12 Q54215203-F8E54352-B46E-4FFE-AEB2-6BE199F75F23 Q55170957-D1E7F7BC-CFB2-4361-A140-377E08D21A49 Q57106000-B90BC555-C79F-41AE-936D-F7A6A781077A Q57107038-C4049C40-F6D3-40BE-9B9A-97C0C79D34A9 Q57115890-937B4A40-3028-4E48-86F4-6B3F88250762 Q58721369-625F0075-1368-46AC-8E7C-63A7B744DA8B Q58725505-2B354F95-AE70-4AE7-885F-8B3B9D2BB817 Q58758451-151F6BB4-716C-41D7-8480-5529C954996C

P2860

Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.

http://www.wikidata.org/entity/Q35314135

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Gene-expression molecular subt ...... importance of immune response.

@ast

Gene-expression molecular subt ...... importance of immune response.

@en

type

label

Gene-expression molecular subt ...... importance of immune response.

@ast

Gene-expression molecular subt ...... importance of immune response.

@en

prefLabel

Gene-expression molecular subt ...... importance of immune response.

@ast

Gene-expression molecular subt ...... importance of immune response.

@en

P1433

Q35314135-F93E7AC1-8E3E-45CE-8DCF-CD0E9D8DE6E0

P1476

Q35314135-6552E954-96EB-4A79-AE68-98C41E37406F

P2093

Q35314135-5DCA0339-9565-4AE3-A753-4C7D8E8FCD0F

Q35314135-62FB422D-1609-4521-B0B7-B81039FACF4A

Q35314135-99CD0E5A-1353-44F6-A48E-73DBD4AD150A

Q35314135-A5AB5120-8D9F-468D-9F3E-05CE6729F85C

Q35314135-B421F0F4-2A0A-47DD-9A88-29ECF19F41A0

Q35314135-D9AB4464-9379-465F-90A7-989D02DB45D7

Q35314135-F4308CDE-EDBD-4FD0-8BD7-563B949F3FDE

P2860

Q35314135-002542E5-2D82-4040-A7BA-DF9D1B0CC015

Q35314135-00527EB9-2A7A-423D-9529-5F0F5A4657CE

Q35314135-0110EA12-3040-432A-AB6D-11D357772CBB

Q35314135-03EAFE00-AEFB-4D86-9D21-C1A858B55F6B

Q35314135-04E121DE-0A1C-4C99-A034-9B4591A34EE6

Q35314135-08D7CF67-E9A6-4F2B-96DA-1E821C88A3EA

Q35314135-0DB667A1-201B-4777-9A3E-AF90D42E846A

Q35314135-0ED87B8E-B2FF-42D2-AD34-8AA7F5BEB026

Q35314135-13EC4D77-DE54-4C66-A70B-04DA07E7030D

Q35314135-175A4A33-26DA-42E1-91AB-F3FC9637672F

P2888

Q35314135-3E94C1DD-A9E5-47D2-B9DC-C4465F230D5B

P304

Q35314135-D93D19AA-0744-4416-9C73-A1EBFCBB3D9E

P31

Q35314135-0F1BDE19-4963-48E4-A727-D9F427F49709

P356

Q35314135-659E7356-CCB6-4982-A1C9-E2A2D5C9F1D3

P478

Q35314135-97FA70F6-3CAB-43B7-936A-647C4BBEE22E

P50

Q35314135-032C46D7-44CC-4EF1-A8DA-F9EF7BBD5FD8

Q35314135-8A3CB6B3-2E51-4D66-B1C5-AED9F1242463

Q35314135-A67959DA-AFE5-4008-85EF-5CA0844FC893

Q35314135-E920C5D7-0FBA-46E5-BA5E-D706A9B75EB9

P577

Q35314135-166B7122-1368-4448-95BA-1F33A455C681

P5875

Q35314135-FC2CD8F6-DC2D-4F4E-A443-A0F991C88FCD

P6179

Q35314135-71962AF1-5D31-44C1-AE4B-0B9FE8422E74

P698

Q35314135-4C16FEAC-B45A-4E9A-9BFD-2BC006F58274

P932

Q35314135-7F00C619-BDE1-4EBC-A000-FBFC71770D7F

P356

S13058-015-0550-Y

P1433

Breast Cancer Research

P1476

Gene-expression molecular subt ...... importance of immune response.

@en

P2093

Antoine Vanier

http://www.w3.org/2001/XMLSchema#string

Catherine Guette

http://www.w3.org/2001/XMLSchema#string

Hamza Lasla

http://www.w3.org/2001/XMLSchema#string

Isabelle Valo

http://www.w3.org/2001/XMLSchema#string

Mario Campone

http://www.w3.org/2001/XMLSchema#string

Véronique Verrièle

http://www.w3.org/2001/XMLSchema#string

Wilfried Gouraud

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Molecular portraits of human breast tumours

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

Repeated observation of breast tumor subtypes in independent gene expression data sets

Triple-Negative Breast Cancer

Alternative activation of macrophages: mechanism and functions

GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists

Microenvironmental regulation of tumor progression and metastasis

Macrophage diversity enhances tumor progression and metastasis

P2888

s13058-015-0550-y

P304

43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13058-015-0550-Y

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Pascal Jézéquel

Catherine Guérin-Charbonnel

Delphine Loussouarn

P577

2015-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275102285

http://www.w3.org/2001/XMLSchema#string

P6179

1008234629

http://www.w3.org/2001/XMLSchema#string

P698

25887482

http://www.w3.org/2001/XMLSchema#string

P932

4389408

http://www.w3.org/2001/XMLSchema#string